Thomas Marth

4.7k total citations
52 papers, 3.4k citations indexed

About

Thomas Marth is a scholar working on Pathology and Forensic Medicine, Immunology and Epidemiology. According to data from OpenAlex, Thomas Marth has authored 52 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 17 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Thomas Marth's work include Whipple's Disease and Interleukins (30 papers), Inflammatory Bowel Disease (7 papers) and Mycobacterium research and diagnosis (7 papers). Thomas Marth is often cited by papers focused on Whipple's Disease and Interleukins (30 papers), Inflammatory Bowel Disease (7 papers) and Mycobacterium research and diagnosis (7 papers). Thomas Marth collaborates with scholars based in Germany, United States and France. Thomas Marth's co-authors include Brian L. Kelsall, Warren Strober, Didier Raoult, Gerhard E. Feurle, Markus F. Neurath, Thomas Schneider, Ivan J. Fuss, Verena Moos, Andreas Stallmach and Björn R. Lúdvíksson and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Thomas Marth

52 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Marth 1.6k 1.2k 536 480 321 52 3.4k
Verena Moos 1.2k 0.8× 714 0.6× 438 0.8× 119 0.2× 545 1.7× 81 2.9k
Stefanie Kunz 355 0.2× 2.5k 2.0× 406 0.8× 227 0.5× 311 1.0× 19 3.4k
Melanie A. Kleinschek 334 0.2× 2.5k 2.0× 420 0.8× 632 1.3× 593 1.8× 18 3.3k
Christiane Pfeiffer 536 0.3× 1.4k 1.1× 248 0.5× 124 0.3× 96 0.3× 39 2.5k
Kyriaki Dunussi‐Joannopoulos 371 0.2× 2.9k 2.3× 305 0.6× 264 0.6× 192 0.6× 29 3.7k
Florian Beigel 344 0.2× 1.6k 1.3× 968 1.8× 1.3k 2.7× 502 1.6× 68 3.4k
Ikuya Tsuge 321 0.2× 1.6k 1.3× 458 0.9× 382 0.8× 191 0.6× 87 3.0k
Shin Sasaki 417 0.3× 471 0.4× 262 0.5× 155 0.3× 207 0.6× 56 1.5k
William O. Dobbins 751 0.5× 476 0.4× 751 1.4× 629 1.3× 1.1k 3.4× 83 3.2k
Julio C. Delgado 351 0.2× 1.2k 1.0× 522 1.0× 164 0.3× 251 0.8× 43 2.3k

Countries citing papers authored by Thomas Marth

Since Specialization
Citations

This map shows the geographic impact of Thomas Marth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Marth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Marth more than expected).

Fields of papers citing papers by Thomas Marth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Marth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Marth. The network helps show where Thomas Marth may publish in the future.

Co-authorship network of co-authors of Thomas Marth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Marth. A scholar is included among the top collaborators of Thomas Marth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Marth. Thomas Marth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marth, Thomas, Verena Moos, Christian Müller, Federico Biagi, & Thomas Schneider. (2016). Tropheryma whipplei infection and Whipple's disease. The Lancet Infectious Diseases. 16(3). e13–e22. 128 indexed citations
2.
Fenollar, Florence, Thomas Marth, Jean‐Christophe Lagier, Emmanouil Angelakis, & Didier Raoult. (2015). Sewage workers with low antibody responses may be colonized successively by several Tropheryma whipplei strains. International Journal of Infectious Diseases. 35. 51–55. 12 indexed citations
3.
Biagi, Federico, Annalisa Schiepatti, Carla Badulli, et al.. (2015). −295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple’s disease. European Journal of Clinical Microbiology & Infectious Diseases. 34(9). 1919–1921. 7 indexed citations
4.
Marth, Thomas. (2014). Complicated Whipple’s disease and endocarditis following tumor necrosis factor inhibitors. World Journal of Cardiology. 6(12). 1278–1278. 19 indexed citations
5.
Feurle, Gerhard E., Verena Moos, Christoph Loddenkemper, et al.. (2013). Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. Journal of Infection. 66(3). 263–270. 47 indexed citations
6.
Feurle, Gerhard E., et al.. (2009). Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease. Gastroenterology. 138(2). 478–486. 119 indexed citations
7.
Marth, Thomas. (2009). New Insights into Whipple’s Disease – A Rare Intestinal Inflammatory Disorder. Digestive Diseases. 27(4). 494–501. 23 indexed citations
8.
Kraemer, Matthias, et al.. (2008). Perioperative adjuvant therapy with infliximab in complicated anal crohn’s disease. International Journal of Colorectal Disease. 23(10). 965–969. 10 indexed citations
9.
Schmidt, Carsten, Thomas Giese, Thomas Marth, et al.. (2005). Expression of Interleukin-12-Related Cytokine Transcripts in Inflammatory Bowel Disease: Elevated Interleukin-23p19 and Interleukin-27p28 in Crohnʼs Disease But Not in Ulcerative Colitis. Inflammatory Bowel Diseases. 11(1). 16–23. 225 indexed citations
10.
Schneider, Thomas, Sabine Ring, Júlia Hoffmann, et al.. (2005). Decreased levels of interleukin-12p40 in the serum of patients with Whipple’s disease. International Journal of Colorectal Disease. 21(2). 114–120. 23 indexed citations
11.
12.
Stallmach, Andreas, Thomas Marth, Nicole Adrian, et al.. (2002). Increased expression of interleukin-12 receptor β2 on lamina propria mononuclear cells of patients with active Crohn's disease. International Journal of Colorectal Disease. 17(5). 303–310. 7 indexed citations
13.
Schmidt, Carsten, Thomas Marth, Bianca M. Wittig, et al.. (2002). Interleukin-12 Antagonists as New Therapeutic Agents in Inflammatory Bowel Disease. Pathobiology. 70(3). 177–183. 22 indexed citations
14.
Stallmach, Andreas & Thomas Marth. (2000). Störungen der Apoptose bei chronisch- entzündlichen Darmerkrankungen - Disturbance of apoptosis in inflammatory bowel disease -. Zeitschrift für Gastroenterologie. 38(10). 873–876. 1 indexed citations
15.
Marth, Thomas, Sabine Ring, Warren Strober, et al.. (2000). Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice. European Journal of Immunology. 30(12). 3478–3486. 36 indexed citations
16.
Marth, Thomas & Brian L. Kelsall. (1997). Regulation of Interleukin-12 by Complement Receptor 3 Signaling. The Journal of Experimental Medicine. 185(11). 1987–1995. 219 indexed citations
17.
Strober, Warren, Brian L. Kelsall, Ivan J. Fuss, et al.. (1997). Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunology Today. 18(2). 61–64. 333 indexed citations
18.
Marth, Thomas & Warren Strober. (1997). Oral tolerance and its modulation by anti-cytokines. Research in Immunology. 148(8-9). 554–561. 4 indexed citations
19.
Marth, Thomas, et al.. (1997). Regulation of transforming growth factor‐β production by interleukin‐12. European Journal of Immunology. 27(5). 1213–1220. 66 indexed citations
20.
Feurle, Gerhard E. & Thomas Marth. (1994). An evaluation of antimicrobial treatment for whipple's disease. Digestive Diseases and Sciences. 39(8). 1642–1648. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verena Moos Breakdown of academic impact, for papers by Stefanie Kunz Breakdown of academic impact, for papers by Melanie A. Kleinschek Breakdown of academic impact, for papers by Christiane Pfeiffer Breakdown of academic impact, for papers by Kyriaki Dunussi‐Joannopoulos Breakdown of academic impact, for papers by Florian Beigel Breakdown of academic impact, for papers by Ikuya Tsuge Breakdown of academic impact, for papers by Shin Sasaki Breakdown of academic impact, for papers by William O. Dobbins Breakdown of academic impact, for papers by Julio C. Delgado
Rankless by CCL
2026